NRC NRC HEALTH
NRC HEALTH (NRC) news
NRC HEALTH is a public biotech or pharmaceutical company listed on NASDAQ under the ticker NRC, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest NRC HEALTH news
We have not published a story on NRC HEALTH yet. When there is news, it will appear here.
NRC HEALTH annual financials
| Line | FY2025 | FY2024 |
|---|---|---|
| Cash from operations | $26.4 million | $34.6 million |
| Cash and equivalents | $4.1 million | $4.2 million |
Questions about NRC HEALTH
What is the ticker symbol of NRC HEALTH?
NRC HEALTH trades under the ticker NRC on NASDAQ.
Where is NRC HEALTH listed?
NRC HEALTH is listed on NASDAQ.
Which country or territory is NRC HEALTH listed under?
Our directory records NRC HEALTH under United States.
Does aibio.space cover NRC HEALTH?
aibio.space lists NRC HEALTH among 2,820 public biotech companies and publishes its news here as stories appear.
How much cash does NRC HEALTH have?
$3.3 million in cash at Jun 30, 2026, per its 10-Q.
Investor discussion: NRC HEALTH
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Capital-markets timeline
- Financings
Filed a final prospectus for a securities offering. SEC Form 424B7. Source
Stock chart
Listing details
- Company
- NRC HEALTH
- Ticker
- NRC
- Listing
- NASDAQ
- Country or territory
- United States
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio